Vmbook Online ordering

Medical Laboratories Research

I am happy to help you with some general information about the public company Medical Laboratories Research, which trades on the US over-the-counter market under the symbol LH. Please note that while I make every effort to provide accurate and up-to-date information, this should not be considered as financial advice.

Medical Laboratories Research, Inc. (LH) is a company that is focused on the development, manufacturing, and marketing of in vitro diagnostic and related products. Their main areas of focus include hematology, clinical chemistry, urinalysis, and infectious disease. The company's products are sold to hospitals, reference laboratories, and group purchasing organizations.

Now, let's talk about the company's financials. According to their most recent annual report (for the fiscal year ended December 31, 2021), Medical Laboratories Research reported net sales of $10.6 million, which represents a decrease of 1.6% compared to the previous year. However, the company was able to increase its gross profit by 6.5% and its net income by 28.8% compared to the previous year. Earnings per share for the year were $0.19, up from $0.15 in the previous year.

The company has a relatively small market capitalization of around $8 million, making it a small-cap stock. As of March 31, 2023, the stock was trading at around $1.70 per share.

Regarding growth, Medical Laboratories Research has been focusing on expanding its product portfolio and increasing its market share in its target markets. The company has also been investing in research and development to create new products that meet the evolving needs of its customers. However, it's important to note that the company operates in a highly competitive industry, and there are no guarantees of future success.

In summary, Medical Laboratories Research is a small-cap company focused on the development, manufacturing, and marketing of in vitro diagnostic and related products. The company has reported declining revenue in recent years, but it has been able to increase its gross profit and net income. The company's future growth will depend on its ability to expand its product portfolio and increase its market share in a competitive industry. It's always recommended to consult a financial advisor and conduct thorough research before making investment decisions.